Advancing molecular diagnostics by empowering laboratories to deliver innovative healthcare information that improves patient care.



Our molecular products give doctors more specific information about clinically relevant aspects of disease, enabling more targeted treatment planning and monitoring of an individual patient's response to therapy. Our donor screening tests are used to identify blood, plasma and organs for HIV and hepatitis, helping to reduce transmission of these serious diseases during transfusions, transplantations, or administration of other medical therapies derived from blood products.

Using a closed-tube format, real-time PCR, together with AmpErase Enzyme reduces the risk of cross-contamination between samples. With its wide dynamic range, a single real-time PCR assay can detect and accurately quantify as little as a few virus particles up to millions, enabling important clinical advancements, such as the highly accurate viral load testing critical to proper assessment of disease progression and response to therapy for HIV and hepatitis.